|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-1-31
|
|
pubmed:abstractText |
The treatment of early-stage Hodgkin's disease (HD) has evolved from radiotherapy alone (RT) to combined-modality therapy (CMT) because of concerns about late adverse effects from high-dose subtotal nodal irradiation (STNI). However, there is little information regarding the long-term results of CMT programs that substantially reduce the dose and extent of radiation. In addition, lowering the total radiation dose may reduce the complication rate without compromising cure. This retrospective study compares the long-term results of STNI with CMT using modestly reduced RT dose in the treatment of early-stage HD.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
605-11
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16446333-Adolescent,
pubmed-meshheading:16446333-Adult,
pubmed-meshheading:16446333-Aged,
pubmed-meshheading:16446333-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16446333-Cause of Death,
pubmed-meshheading:16446333-Chemotherapy, Adjuvant,
pubmed-meshheading:16446333-Child,
pubmed-meshheading:16446333-Child, Preschool,
pubmed-meshheading:16446333-Coronary Disease,
pubmed-meshheading:16446333-Disease-Free Survival,
pubmed-meshheading:16446333-Female,
pubmed-meshheading:16446333-Hodgkin Disease,
pubmed-meshheading:16446333-Humans,
pubmed-meshheading:16446333-Incidence,
pubmed-meshheading:16446333-Lymph Nodes,
pubmed-meshheading:16446333-Male,
pubmed-meshheading:16446333-Middle Aged,
pubmed-meshheading:16446333-Neoplasm Staging,
pubmed-meshheading:16446333-Neoplasms, Radiation-Induced,
pubmed-meshheading:16446333-Radiotherapy, Adjuvant,
pubmed-meshheading:16446333-Radiotherapy Dosage,
pubmed-meshheading:16446333-Retrospective Studies,
pubmed-meshheading:16446333-Risk Assessment,
pubmed-meshheading:16446333-Survival Analysis
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC 27710, USA. koont005@radonc.duke.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
